U.S. Markets closed

BRSS, GDI, EMCI, IMI Shareholder Alert: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders – BRSS, GDI, EMCI, IMI

NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating Global Brass and Copper Holdings, Inc. (BRSS), Gardner Denver Holdings, Inc. (GDI), EMC Insurance Group Inc. (EMCI), and Intermolecular, Inc. (IMI) in connection with the sale of these companies. On behalf of the shareholders of these companies, Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Global Brass and Copper Holdings, Inc. (BRSS)
The investigation concerns whether Global Brass and its Board of Directors violated the federal securities laws in connection with the proposed sale of Global Brass to Wieland-Werke AG. To learn more about the Global Brass investigation and your legal rights and options, please visit: Global Brass (BRSS) Merger.

Gardner Denver Holdings, Inc. (GDI)
The investigation concerns whether Gardner Denver and its Board of Directors violated the federal securities laws in connection with the proposed sale of Gardner Denver to Ingersoll-Rand plc. To learn more about the Gardner Denver investigation and your legal rights and options, please visit: Gardner Denver (GDI) Merger.

EMC Insurance Group Inc. (NASDAQ: EMCI) 
The investigation concerns whether EMC and its Board of Directors violated the federal securities laws in connection with the proposed sale of EMC to Employers Mutual Casualty Company. To learn more about the EMC investigation and your legal rights and options, please visit: EMC Insurance (EMCI) Merger.

Intermolecular, Inc. (NASDAQ: IMI) 
The investigation concerns whether Intermolecular and its Board of Directors violated the federal securities laws in connection with the proposed sale of Intermolecular to a wholly owned subsidiary of Merck KGaA. To learn more about the Intermolecular investigation and your legal rights and options, please visit: Intermolecular (IMI) Merger.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com